Research Project: Study of patient characteristics associated with early ART initiation in patients participating in the primary HIV infection study

Postdoc Year(s): 2014-2015

Dr. Wei Cao was the CTN International Postdoctoral Fellow for 2014-2015. A physician from Beijing, China, she worked closely with Vaccines and Immunotherapies Core co-lead Dr. Jean-Pierre Routy in Montreal during her fellowship. Dr. Cao’s research focus is on the acute and early phases of HIV, an area she feels has been underrepresented. “In my clinic and lab in China, we have established large cohorts of people living with HIV, but the study of early infection has just started,” she notes. 

Under the guidance of Dr. Routy and the CTN 257 study team, she has reviewed recent progress in understanding primary HIV infection and the effect of early ART on immune functions and talent reservoirs. They currently have a paper on their findings under review.

Dr. Cao looks forward to bringing her experiences as a CTN fellow back to Beijing. “Working with the Montreal primary HIV infection (PHI) cohort has provided valuable insights for our future clinical practice and clinical studies in China.”

In addition, Dr. Cao also worked on a minor project; assessing HIV reservoir changes in HIV/HCV co-infected patients with sustained virologic response (SVR) following hepatitis C therapy.

Ms. Cao received her MD at the Peking Unon Medical College in Beijing, China, in 2008. Since then, she has done research work at the College’s HIV/AIDS Center.